SCAI Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2a Study to Evaluate the Efficacy and Safety of SCAI-005 Ophthalmic Solution in Subjects With Neovascular Age-related Macular Degeneration (NCT07607561) | SCAI Therapeutics | 2026-11-01 |
| Clinical Study for the Evaluation of Safety and Tolerability of SCAI-005 Eye Drops (NCT06969001) | SCAI Therapeutics | 2025-05-29 |
| Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis (NCT05733624) | SCAI Therapeutics | 2023-01-05 |
Track SCAI Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.